These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 17420270)

  • 1. Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis.
    Crozat K; Hoebe K; Ugolini S; Hong NA; Janssen E; Rutschmann S; Mudd S; Sovath S; Vivier E; Beutler B
    J Exp Med; 2007 Apr; 204(4):853-63. PubMed ID: 17420270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene editing of hematopoietic stem cells restores T-cell response in familial hemophagocytic lymphohistiocytosis.
    Dettmer-Monaco V; Weißert K; Ammann S; Monaco G; Lei L; Gräßel L; Rhiel M; Rositzka J; Kaufmann MM; Geiger K; Andrieux G; Lao J; Thoulass G; Schell C; Boerries M; Illert AL; Cornu TI; Ehl S; Aichele P; Cathomen T
    J Allergy Clin Immunol; 2024 Jan; 153(1):243-255.e14. PubMed ID: 37595758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse Cytomegalovirus Infection in BALB/c Mice Resembles Virus-Associated Secondary Hemophagocytic Lymphohistiocytosis and Shows a Pathogenesis Distinct from Primary Hemophagocytic Lymphohistiocytosis.
    Brisse E; Imbrechts M; Put K; Avau A; Mitera T; Berghmans N; Rutgeerts O; Waer M; Ninivaggi M; Kelchtermans H; Boon L; Snoeck R; Wouters CH; Andrei G; Matthys P
    J Immunol; 2016 Apr; 196(7):3124-34. PubMed ID: 26903481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice.
    Krebs P; Crozat K; Popkin D; Oldstone MB; Beutler B
    Blood; 2011 Jun; 117(24):6582-8. PubMed ID: 21551232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel and atypical splicing mutation in a compound heterozygous UNC13D defect presenting in Familial Hemophagocytic Lymphohistiocytosis triggered by EBV infection.
    Alsina L; Colobran R; de Sevilla MF; Català A; Viñas L; Ricart S; Plaza AM; Lois S; Juan M; Pujol-Borrell R; Martinez-Gallo M
    Clin Immunol; 2014 Aug; 153(2):292-7. PubMed ID: 24825797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentiviral Gene Therapy for Familial Hemophagocytic Lymphohistiocytosis Type 3, Caused by
    Takushi SE; Paik NY; Fedanov A; Prince C; Doering CB; Spencer HT; Chandrakasan S
    Hum Gene Ther; 2020 Jun; 31(11-12):626-638. PubMed ID: 32253931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients.
    Bryceson YT; Rudd E; Zheng C; Edner J; Ma D; Wood SM; Bechensteen AG; Boelens JJ; Celkan T; Farah RA; Hultenby K; Winiarski J; Roche PA; Nordenskjöld M; Henter JI; Long EO; Ljunggren HG
    Blood; 2007 Sep; 110(6):1906-15. PubMed ID: 17525286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lytic viral replication and immunopathology in a cytomegalovirus-induced mouse model of secondary hemophagocytic lymphohistiocytosis.
    Brisse E; Imbrechts M; Mitera T; Vandenhaute J; Wouters CH; Snoeck R; Andrei G; Matthys P
    Virol J; 2017 Dec; 14(1):240. PubMed ID: 29258535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A CD57
    Hori M; Yasumi T; Shimodera S; Shibata H; Hiejima E; Oda H; Izawa K; Kawai T; Ishimura M; Nakano N; Shirakawa R; Nishikomori R; Takada H; Morita S; Horiuchi H; Ohara O; Ishii E; Heike T
    J Clin Immunol; 2017 Jan; 37(1):92-99. PubMed ID: 27896523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Founder effects in two predominant intronic mutations of UNC13D, c.118-308C>T and c.754-1G>C underlie the unusual predominance of type 3 familial hemophagocytic lymphohistiocytosis (FHL3) in Korea.
    Seo JY; Song JS; Lee KO; Won HH; Kim JW; Kim SH; Lee SH; Yoo KH; Sung KW; Koo HH; Kang HJ; Shin HY; Ahn HS; Han DK; Kook H; Hwang TJ; Lyu CJ; Lee MJ; Kim JY; Park SS; Lim YT; Kim BE; Koh KN; Im HJ; Seo JJ; Kim HJ;
    Ann Hematol; 2013 Mar; 92(3):357-64. PubMed ID: 23180437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a large UNC13D gene duplication in a patient with familial hemophagocytic lymphohistiocytosis type 3.
    Hiejima E; Shibata H; Yasumi T; Shimodera S; Hori M; Izawa K; Kawai T; Matsuoka M; Kojima Y; Ohara A; Nishikomori R; Ohara O; Heike T
    Clin Immunol; 2018 Jun; 191():63-66. PubMed ID: 29596912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIF1A is a critical downstream mediator for hemophagocytic lymphohistiocytosis.
    Huang R; Hayashi Y; Yan X; Bu J; Wang J; Zhang Y; Zhou Y; Tang Y; Wu L; Xu Z; Liu X; Wang Q; Zhou J; Xiao Z; Bridges JP; Marsh RA; Zhang K; Jordan MB; Li Y; Huang G
    Haematologica; 2017 Nov; 102(11):1956-1968. PubMed ID: 28860338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine-Mediated Activation of NK Cells during Viral Infection.
    Freeman BE; Raué HP; Hill AB; Slifka MK
    J Virol; 2015 Aug; 89(15):7922-31. PubMed ID: 25995253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, immunological and genetic findings in patients with UNC13D deficiency (FHL3): A systematic review.
    Amirifar P; Ranjouri MR; Abolhassani H; Moeini Shad T; Almasi-Hashiani A; Azizi G; Moamer S; Aghamohammadi A; Yazdani R
    Pediatr Allergy Immunol; 2021 Jan; 32(1):186-197. PubMed ID: 32679608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial hemophagocytic lymphohistiocytosis in a 6-week-old male infant.
    Jakovljević G; Kardum-Skelin I; Rogosić S; Culić S; Stepan J; Gagro A; Skarić I; Mikecin L; Bonevski A; Barisić I; Nakić M
    Coll Antropol; 2010 Jun; 34(2):631-4. PubMed ID: 20698142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus generates long-lived antigen-specific NK cells with diminished bystander activation to heterologous infection.
    Min-Oo G; Lanier LL
    J Exp Med; 2014 Dec; 211(13):2669-80. PubMed ID: 25422494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D.
    Meeths M; Chiang SC; Wood SM; Entesarian M; Schlums H; Bang B; Nordenskjöld E; Björklund C; Jakovljevic G; Jazbec J; Hasle H; Holmqvist BM; Rajic L; Pfeifer S; Rosthøj S; Sabel M; Salmi TT; Stokland T; Winiarski J; Ljunggren HG; Fadeel B; Nordenskjöld M; Henter JI; Bryceson YT
    Blood; 2011 Nov; 118(22):5783-93. PubMed ID: 21931115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 253-kb inversion and deep intronic mutations in UNC13D are present in North American patients with familial hemophagocytic lymphohistiocytosis 3.
    Qian Y; Johnson JA; Connor JA; Valencia CA; Barasa N; Schubert J; Husami A; Kissell D; Zhang G; Weirauch MT; Filipovich AH; Zhang K
    Pediatr Blood Cancer; 2014 Jun; 61(6):1034-40. PubMed ID: 24470399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative
    Galgano D; Soheili T; Voss M; Torralba-Raga L; Tesi B; Cichocki F; Andre I; Rettig J; Cavazzana M; Bryceson Y
    Front Immunol; 2020; 11():1154. PubMed ID: 32582217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UNC13D mutation presenting as fulminant familial hemophagocytic lymphohistiocytosis.
    Liao CH; Lee NC; Jou ST; Chiang BL; Yu HH
    J Microbiol Immunol Infect; 2020 Dec; 53(6):1039-1041. PubMed ID: 32327331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.